Use of Interferon-Gamma Release Assays in a Health Care Worker Screening Program: Experience from a Tertiary Care Centre in the United States
BACKGROUND: Interferon-gamma release assays including the QuantiFERON-TB Gold In-Tube test (QFT-GIT [Cellestis Ltd, Australia]) may be used in place of the tuberculin skin test (TST) in surveillance programs for Mycobacterium tuberculosis infection control. However, data on performance and practical...
Saved in:
| Main Authors: | Manish Joshi, Thomas P Monson, Gail L Woods |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Canadian Respiratory Journal |
| Online Access: | http://dx.doi.org/10.1155/2012/576324 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Benefit of Interferon-Gamma Release Assay for Diagnosis of Extrapulmonary Tuberculosis
by: Cleopas Martin Rumende, et al.
Published: (2018-06-01) -
The Benefit of Interferon-Gamma Release Assay for Diagnosis of Extrapulmonary Tuberculosis
by: Cleopas Martin Rumende, et al.
Published: (2018-06-01) -
Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.
by: Thomas Stig Hermansen, et al.
Published: (2014-01-01) -
WCN25-808 Concordance between Cy-TB and Interferon gamma release assay (IGRA) for diagnosing latent Tuberculosis infection in chronic kidney disease patients attending Nephrology OPD in an Indian tertiary care centre
by: Sourabh Sharma, et al.
Published: (2025-02-01) -
Interferon-Gamma Release Assays Are a Better Tuberculosis Screening Test for Hemodialysis Patients: A Study and Review of the Literature
by: J Grant, et al.
Published: (2012-01-01)